Anti-Human Cytokeratin 8 [1E8-C6-B4]

Absolute Antibody

Anti-Human Cytokeratin 8 [1E8-C6-B4]

7

The original antibody detected CK 8 by western blot from BT20 breast cancer cells. Immunofluorescence was performed on BT20 cells using this antibody, showing the carboxyl terminus of CK 8 was exposed on the surfaces of breast cancer cells. The Fab fragment of the antibody was used for inhibition experiments on breast cancer cell lines BT20, MDA-MB-157, MCF-7 and purified CK 8. Results showed a decreased plasminogen binding in all the experiments. The Fab fragment was used to study the role of cell-surface CK 8 in promoting the activation of plasminogen by t-PA in MCF-7 cells; preincubation of MCF-7 cells with the Fab fragment caused a concentration-dependent decrease in the ability of the cell cultures to promote plasminogen activation (Hembrough et al, 1996; pmid:8810346).

ImmunoFluorescence, ImmunoPrecipitation, Western Blot

WB, IP, IF

Research Use Only

Monoclonal

1E8-C6-B4

KRT8

keratin 8

CARD2; CK8; CK-8; CYK8; cytokeratin-8; K2C8; K8; keratin 8, type II; keratin, type II cytoskeletal 8; KO; type-II keratin Kb8

Mouse

IgG1

Keratin, type II cytoskeletal 8

Human

The original antibody was generated by immunizing mice against the C-terminus (amino acids 472-483) of human Cytokeratin 8.

-20°C,2°C to 8°C

12352203